Loteprednol Etabonate (Submicron) Ophthalmic Gel 0.38%: A Review in Post-Operative Inflammation and Pain Following Ocular Surgery

Loteprednol etabonate ophthalmic gel 0.38% (Lotemax(®) SM; hereafter referred to as loteprednol etabonate gel 0.38%) is a topical ophthalmic corticosteroid approved in the USA for the treatment of post-operative inflammation and pain following ocular surgery. This formulation provides improved drug...

Descripción completa

Detalles Bibliográficos
Autores principales: Kang, Connie, Keam, Susan J., Shirley, Matt, Syed, Yahiya Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Adis Drug Evaluation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7736007/
https://www.ncbi.nlm.nih.gov/pubmed/32172521
http://dx.doi.org/10.1007/s40261-020-00899-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7736007/
https://www.ncbi.nlm.nih.gov/pubmed/32172521
http://dx.doi.org/10.1007/s40261-020-00899-2

Ejemplares similares